Therefore, in this study, we evaluated the GR, Sgk1, and NDRG1 status in ESCC before and after NAC, and analyzed the clinical courses of the patients to assess the therapeutic efficacy of NAC and prognosis of the disease. This evidence concerns the gene NR3C1 and esophageal squamous cell carcinoma.